7 Results for "

Src Inhibitor1

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Src Inhibitor1" in MCE Product Catalog:

17
17 Cited Publications
Cat. No.: HY-101053
CAS No.: 179248-59-0
Purity:  99.93%
Synonyms: Src Kinase Inhibitor 1; Src-l1
Target:  

Src

Research Areas:  

Cancer

Src Inhibitor 1 is a potent, ATP-competitive and selective dual site Src tyrosine kinase inhibitor with IC50 values of 44 nM for Src and 88nM for Lck.
loading...
    loading...
Cat. No.: HY-107024
CAS No.: 105250-85-9
Purity:  99.77%
Synonyms: OGP(10-14); Historphin
Target:  

Src

Research Areas:  

Others

Osteogenic Growth Peptide (10-14) (OGP(10-14)), the C-terminal truncated pentapeptide of osteogenic growth peptide (OGP), retains the full OGP-like activity. Osteogenic Growth Peptide (10-14) is responsible for the binding to the OGP receptor and activates an intracellular Gi-protein-MAP kinase signaling pathway. Osteogenic Growth Peptide (10-14) is a potent mitogen and stimulator of osteogenesis and hematopoiesis. Osteogenic Growth Peptide (10-14) acts as a Src inhibitor .
loading...
    loading...
Cat. No.: HY-151577
CAS No.: 2816059-41-1
Purity:  98.58%
Target:  

STAT Apoptosis

Research Areas:  

Cancer

STAT3-SH2 domain inhibitor 1 is a potent Src Homology 2 (SH2) Domain of STAT3 (STAT3-SH2 domain) inhibitor with a Kd value of 1.57 μM. STAT3-SH2 domain inhibitor 1 inhibits STAT3 signaling transduction and transcriptional activation. STAT3-SH2 domain inhibitor 1 induces apoptosis in gastric cancer cells. STAT3-SH2 domain inhibitor 1 can be used in research of cancer .
loading...
    loading...
Cat. No.: HY-133794
CAS No.: 910297-52-8
Purity:  99.27%
Target:  

Drug Metabolite

Research Areas:  

Cancer

Dasatinib N-oxide is a minor metabolite of Dasatinib. Dasatinib is a potent and orally active dual Src/Bcr-Abl inhibitor .
loading...
    loading...
Cat. No.: HY-133794S
CAS No.: 1189988-36-0
Dasatinib N-oxide-d8 is the deuterium labeled Dasatinib N-oxide. Dasatinib N-oxide is a minor metabolite of Dasatinib. Dasatinib is a potent and orally active dual Src/Bcr-Abl inhibitor .
loading...
    loading...
Cat. No.: HY-112800
CAS No.: 428478-94-8
Purity:  98.05%
Target:  

Phosphatase

Research Areas:  

Metabolic Disease

cyt-PTPε Inhibitor-1 is a potent cytosolic protein tyrosine phosphatase epsilon (cyt-PTPε) inhibitor, binds to the catalytic domain of cyt-PTPε, blocks c-Src activation (dephosphorylation of c-Src), and exhibits anti-osteoclastic activity .
loading...
    loading...
Cat. No.: HY-101053R
CAS No.: 179248-59-0
Synonyms: Src Kinase Inhibitor 1 (Standard); Src-l1 (Standard)
Target:  

Src Reference Standards

Research Areas:  

Cancer

Src Inhibitor 1 (Standard) is the analytical standard of Src Inhibitor 1 (HY-101053). This product is intended for research and analytical applications. Src Inhibitor 1 is a potent, ATP-competitive and selective dual site Src tyrosine kinase inhibitor with IC50 values of 44 nM for Src and 88nM for Lck.
loading...
    loading...